<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Spinal cord stimulation (SCS) is a well established therapy in the treatment for <z:hpo ids='HP_0011010'>chronic</z:hpo> pain </plain></SENT>
<SENT sid="1" pm="."><plain>SCS has also been shown to increase peripheral blood flow and is now an accepted treatment in the management of ischemic <z:hpo ids='HP_0009763'>limb pain</z:hpo> and <z:mp ids='MP_0006112'>angina</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>There is a growing body of evidence that cervical spinal cord stimulation also increases cerebral blood flow (CBF) in both animal and human models </plain></SENT>
<SENT sid="3" pm="."><plain>SCS could potentially impact on the treatment of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> and <z:hpo ids='HP_0001297'>stroke</z:hpo> by an increase in CBEF The utility of SCS is also being explored in novel applications such as adjunctive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> therapy, where resistance to therapy conferred by tissue <z:mp ids='MP_0005039'>hypoxia</z:mp> may be ameliorated by CBF augmentation </plain></SENT>
</text></document>